Syphilinum homeopathic drug recalled for manufacturing practice deviations
Washington Homeopathic Products is recalling Syphilinum homeopathic products in multiple potencies due to current good manufacturing practice deviations. The affected products were distributed nationwide.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall initiated voluntarily by the manufacturer due to current good manufacturing practice deviations, with no reported illnesses or injuries. The recall is precautionary in nature, consistent with a Moderate severity classification.
Plain-English summary
Washington Homeopathic Products, Inc. is recalling Syphilinum homeopathic product in multiple potencies (9C, 30C, 200C, 10X, and 12X) supplied as liquid pellets. The affected lot numbers are 20390, 20441, and 20389.
The recall was initiated due to current good manufacturing practice (cGMP) deviations. Washington Homeopathic Products voluntarily initiated the recall on May 13, 2022. The products were distributed nationwide throughout the United States.
Consumers who have purchased this product should contact Washington Homeopathic Products, Inc. in Berkeley Springs, West Virginia, or consult with their healthcare provider for guidance on this recall.
The recalled product
- Product
- Syphilinum, Potency: 9C, 30C, 200C, 10X, 12X, Liquid Pellets, Rx only, Washington Homeopathic Products, 260 JR Hawvermale Way, Berkeley Springs, WV 25411
- Manufacturer
- Washington Homeopathic Products, Inc.
- Category
- Drug — Homeopathic
- Hazard
- cgmp-deviation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- Lot# 20390
- 20441
- 20389
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModeratePovi-One Povidone-Iodine 10% Topical Drug Recall for Sub Potency
FDA (Drugs) · 2026-07-01
- ModerateSensipar cinacalcet hydrochloride tablets recalled for CGMP deviations
FDA (Drugs) · 2026-07-01
- ModerateSensipar Cinacalcet Tablets Recalled Due to CGMP Deviations
FDA (Drugs) · 2026-07-01
- ModerateSensipar (Cinacalcet Hydrochloride) Tablets Recalled for CGMP Deviations
FDA (Drugs) · 2026-07-01